Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Os-Cal TV ad

This article was originally published in The Tan Sheet

Executive Summary

Breaking the week of Nov. 8, SmithKline Beecham television ad campaign for Os-Cal Calcium Supplement features figure skater Peggy Fleming. Developed by Creative Advertising Solutions, New York, the 15- and 30-second commercials are tagged "Don't Take Chances, Take Os-Cal." The 30-second spot begins with Fleming skating. "Boy, the things we don't think about when we're young. I'm Peggy Fleming, and now that I'm older and wiser, I think about the brittle bones that I could get if I wasn't taking a calcium supplement," she says. Fleming continues in a voiceover, "Only Os-Cal has been proven effective in more clinical studies, and comes from a natural calcium source, and has been recommended by more doctors than Caltrate and Citracal combined." Os-Cal contains calcium from oyster shells

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

OM011381

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel